Prognostic value of estrogen receptor α and progesterone receptor conversion in distant breast cancer metastases

Should liver metastases of breast cancer be biopsied to improve treatment choice?

(2011) G. Curigliano et al.   ANNALS OF ONCOLOGY

HER2 Protein and Gene Variation between Primary and Metastatic Breast Cancer: Significance and Impact on Patient Care

(2011) A. Fabi et al.   CLINICAL CANCER RESEARCH

Estrogen Receptor and Progesterone Receptor As Predictive Biomarkers of Response to Endocrine Therapy: A Prospectively Powered Pathology Study in the Tamoxifen and Exemestane Adjuvant Multinational Trial

(2011) John M.S. Bartlett et al.   JOURNAL OF CLINICAL ONCOLOGY

Comparison of hormonal receptor and HER-2 status between breast primary tumours and relapsing tumours: clinical implications of progesterone receptor loss

(2011) Giuseppe Bogina et al.   VIRCHOWS ARCHIV

Hormone Receptor and c-ERBB2 Status in Distant Metastatic and Locally Recurrent Breast Cancer

(2010) Pushpalatha K.A. Idirisinghe et al.   AMERICAN JOURNAL OF CLINICAL PATHOLOGY

HER2 status in a population-derived breast cancer cohort: discordances during tumor progression

(2010) Ulla Wilking et al.   BREAST CANCER RESEARCH AND TREATMENT

Stability of estrogen receptor status in breast carcinoma

(2010) Yun Gong et al.   CANCER

American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Immunohistochemical Testing of Estrogen and Progesterone Receptors in Breast Cancer

(2010) M. Elizabeth H. Hammond et al.   JOURNAL OF CLINICAL ONCOLOGY

Prognostic impact of discordance between triple-receptor measurements in primary and recurrent breast cancer

(2009) C. Liedtke et al.   ANNALS OF ONCOLOGY

Does confirmatory tumor biopsy alter the management of breast cancer patients with distant metastases?

(2009) C. Simmons et al.   ANNALS OF ONCOLOGY

Prognostic factors in 1038 women with metastatic breast cancer

(2008) R. Largillier et al.   ANNALS OF ONCOLOGY

HER-2/neu expression in primary and metastatic breast cancer

(2008) Elyse E. Lower et al.   BREAST CANCER RESEARCH AND TREATMENT

Discordance between Receptor Status in Primary and Metastatic Breast Cancer: an Exploratory Study of Bone and Bone Marrow Biopsies

(2008) E. Amir et al.   CLINICAL ONCOLOGY

Comparison of HER-2 and Hormone Receptor Expression in Primary Breast Cancers and Asynchronous Paired Metastases: Impact on Patient Management

(2008) V. Guarneri et al.   ONCOLOGIST